Molecular pathways associated with enzalutamide response in men with metastatic castration resistant prostate cancer

Trial Profile

Molecular pathways associated with enzalutamide response in men with metastatic castration resistant prostate cancer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Jul 2014

At a glance

  • Drugs Enzalutamide (Primary)
  • Indications Prostate cancer
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 23 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top